Merck & Co Inc logo

Merck & Co Inc

BSP:MRCK34 (USA)  
R$ 65.99 (+0.73%) Sep 21
On watch
P/E:
88.74
P/B:
7.10
Market Cap:
R$ 1.34T ($ 271.36B)
Enterprise V:
R$ 1.49T ($ 301.59B)
Volume:
6.10K
Avg Vol (2M):
5.47K
Also Trade In:
Volume:
6.10K
Market Cap R$:
1.34T
Market Cap $:
271.36B
PE Ratio:
88.74
Avg Vol (2M):
5.47K
Enterprise Value R$:
1.49T
Enterprise Value $:
301.59B
PB Ratio:
7.10

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2023-10-27 Est.)

BSP:MRCK34's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 299,415.262
EPS (TTM) (R$) 0.91
Beta -0.35
Volatility % 21.28
14-Day RSI 46.89
14-Day ATR (R$) 1.273566
20-Day SMA (R$) 66.692
12-1 Month Momentum % 24.14
52-Week Range (R$) 53.01 - 77.02
Shares Outstanding (Mil) 20,300.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price(R$)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(BSP:MRCK34)'s stock price today?
The current price of BSP:MRCK34 is R$65.99. The 52 week high of BSP:MRCK34 is R$77.02 and 52 week low is R$53.01.
When is next earnings date of Merck & Co Inc(BSP:MRCK34)?
The next earnings date of Merck & Co Inc(BSP:MRCK34) is 2023-10-27 Est..
Does Merck & Co Inc(BSP:MRCK34) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(BSP:MRCK34) is 2.77% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(BSP:MRCK34) was 2.33. The lowest was 0.44. And the median was 1.09. The  Forward Dividend Yield % of Merck & Co Inc(BSP:MRCK34) is 2.77%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release